New Alliance Capital
VC Fund
Shanghai, China
New Alliance Capital is a venture capital and private equity firm that specializes in early, growth stage and pre-IPO investments. It primarily invest in high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services industry sectors. New AllianceCapital typically invests between $4.71 million and $31.41 million. Qu Liefeng founded it in 2008, with its headquarters in Shanghai in China.
- Total investments:
- 88
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries New Alliance Capital invests in
Stages New Alliance Capital invests in
Countries New Alliance Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.6M–$47M
- Series B
- $2.8M–$50M
- Series C
- $14M–$220M
Investment Focus
Industry
- Health Care 18 (20%)
- Manufacturing 15 (17%)
- Medical 13 (15%)
- Biotechnology 12 (14%)
- Biopharma 8 (9%)
Stage
- Series A 19 (22%)
- Series B 18 (20%)
- Series C 11 (13%)
- Series D 8 (9%)
- Venture - Series Unknown 7 (8%)
Country
- China 61 (69%)
- United States 3 (3%)
- Israel 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Liefeng Qu
Founder and partner
|
Founder and partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Futuring Robot
|
Futuring Robot is a developer of dual-arm home service robots focusing on C-end home scenarios. | $147.7M / Seed / Jul 22, 2026 | |
iCamumo
|
Aikai Biotech is focused on developing a new generation of off-the-shelf general-purpose cell therapy pharmaceuticals using iPSC. | $14.4M / Series A / Mar 09, 2026 | |
|
Futuring Robot
|
Futuring Robot is a developer of dual-arm home service robots focusing on C-end home scenarios. | Seed / Mar 09, 2026 | |
Aerofugia
|
Aerofugia is a technology company with low-altitude travel and vehicle-mounted flight as its core, and a practitioner of the new general aviation strategy under Geely Technology Group. | $144M / Series C / Feb 02, 2026 | |
Leju Robotics
|
Leju Robotics focuses on researching and developing, marketing, and manufacturing of the robot. It gathers one group of young and brilliant elites in the field of Robotics and A.I, possesses 100% independent IP of Robotics hardware and control system, even masters the related core technologies of Robotics, from mechanical design, core partsmanufacturing to A.I algorithm.With one young & enthusiastic talent team, they are always creative for the most inspirational robot and endowing robot humanoid outlook and wisdom of the human being closely.Leju Robotics was founded in 2016 and is headquartered in Shenzhen, Guangdong, China. | $210.5M / Private Equity / Oct 22, 2025 | |
|
Leju Robotics
|
Leju Robotics focuses on researching and developing, marketing, and manufacturing of the robot. It gathers one group of young and brilliant elites in the field of Robotics and A.I, possesses 100% independent IP of Robotics hardware and control system, even masters the related core technologies of Robotics, from mechanical design, core partsmanufacturing to A.I algorithm.With one young & enthusiastic talent team, they are always creative for the most inspirational robot and endowing robot humanoid outlook and wisdom of the human being closely.Leju Robotics was founded in 2016 and is headquartered in Shenzhen, Guangdong, China. | Venture - Series Unknown / Jun 10, 2025 | |
Core Medical Technology
|
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China. | $100M / Series D / Apr 24, 2025 | |
Puxi Crystal
|
Pu Enjing engaged in the independent research and development of high-end polymer materials. | Series B / Jan 22, 2025 | |
Huali Juneng
|
Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical. | $110.6M / Seed / Nov 18, 2024 | |
Positive Sequence Biology
|
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies. | $13.9M / Series A / Aug 08, 2024 | |
| See all 88 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does New Alliance Capital invest in?
New Alliance Capital invests primarily in Health Care, Manufacturing and Medical startups, most often at Series A and Series B stage. Most of the 88 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is New Alliance Capital's check size?
New Alliance Capital typically joins rounds of $1.6M–$47M at Series A, $2.8M–$50M at Series B and $14M–$220M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds New Alliance Capital participates in.
How do I contact New Alliance Capital?
Public channels for New Alliance Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at New Alliance Capital?
The team at New Alliance Capital includes Liefeng Qu (Founder and partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
